Compare ETFs
Up to five funds side by side: fees, size, yields, performance, risk, top holdings and sector mix, with a normalized total-return chart.
| Metric |  PJP Invesco Pharmaceuticals ETF |
|---|---|
| Price | 122.88 +1.56% |
| Issuer | Invesco |
| AUM | $541.0M |
| Expense Ratio | 0.58% |
| Yield (TTM) | 0.92% |
| Inception | Jun 23, 2005 |
| Holdings | 28 |
| Avg Volume | 36.91K |
| YTD | +17.54% |
| 1Y total | +30.78% |
| 3Y total (ann.) | +20.38% |
| 5Y total (ann.) | +10.79% |
| Volatility 1Y | 16.99% |
| Sharpe 1Y | 1.87 |
| Max drawdown 1Y | -9.44% |
| Beta vs S&P 500 (3Y) | 0.521 |
| Top 10 holdings | ABBV 5.87% GILD 5.73% PFE 5.58% JNJ 5.40% LLY 5.39% AMGN 5.28% MRK 5.25% ABT 4.83% AMRX 3.57% LGND 3.44% |
| Sector mix | Healthcare 100.00% |
Total Return, normalized
Dividend-adjusted daily closes over the last 12 months, normalized to 0% at the range start.
Market data delayed approximately 15–20 minutes unless otherwise indicated. Comparison presents measurable characteristics only; it is not advice about which fund suits anyone.